Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | YARS2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
mRNA | CTD-2207O23.12 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
mRNA | WASF1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
mRNA | TCF7L2 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0006 |
mRNA | PROCA1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | RAMP2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | SESTD1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | ELAVL4 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0006 |
mRNA | GLYATL3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
mRNA | NCOA2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |